November 29, 2011

Rheumatic Diseases Research Core Centers federal limited submission funding opportunity announced

Federal Limited Submission Funding Opportunities

General guidelines
All applicants for federal limited submission funding opportunities should notify the Office of Research of their intention to apply. An internal proposal should be submitted; if necessary a faculty review committee will select the institutional applicant(s). Unless otherwise specified, internal proposals should include the following:

• Faculty PI/PD(s)
• Tentative title of the intended proposal
• Names of other key faculty, departments expected to participate
• A brief (one page maximum) summary of the scope and content of the program.

Additional information may be requested.

Questions? Contact Susan Meyn in the Office of Research for more information, or to submit an internal proposal.


Recent Funding Opportunity Announcements
Rheumatic Diseases Research Core Centers (P30)

Vanderbilt is limited to a single application to this program.

Internal Proposal Deadline: Dec. 15.
Application Due Date: March 1, 2012

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) invites applications for Research Core Centers (P30s) in rheumatic diseases. The Rheumatic Diseases Research Core Centers (RDCCs) will provide shared facilities and services to groups of established, currently funded investigators addressing scientific problems in rheumatic diseases, in order to improve efficiency, accelerate the pace of research, and ensure greater productivity.
Research in rheumatic diseases is at a stage where a number of areas are making broad advances that can be effectively fostered by research Core Centers. Examples of these areas include, but are not limited to:
• Mechanisms of autoimmunity underlying rheumatic diseases, including animal models and defined clinical populations. This also includes identification of environmental factors which contribute to development of rheumatic diseases.
• Genetic basis of rheumatic diseases and their manifestations, including animal models, defined clinical populations, and genome-wide association studies.
• Mechanisms underlying organ damage in rheumatic diseases, including inflammatory processes.
• Identification of new risk factors and biomarkers and development of technological approaches to evaluate them in order to predict disease susceptibility pre-clinically and/or more reliably.

The choice of a research area(s) upon which the RDCC would focus is made by the investigators.

In addition to providing services and resources to facilitate independently funded research projects, the Core Centers are encouraged to enhance the research environment and promote synergistic collaborations among the Center Investigators (the investigators of the research base). Scientific core personnel should help to educate the Center Investigators in the capabilities and limitations of the technologies employed by the scientific cores. Core personnel should be involved with the investigators in designing the experiments and interpreting the results. The technologies of the cores should not only evolve with the science conducted by the Center Investigators, but the cores should help to drive the science with increasingly sophisticated and powerful technologies.